Deepan Selvadurai is an Ophthalmology physician affiliated with Williams. OpenAlex indexes 7 publications with 264 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3055 Southwestern Blvd Ste 108
Orchard Park, NY 141271231
Telephone
716-671-9020Provider last certified this registry record 23 Feb 2021.
Clinical trials
- Aqueous Outflow Facility Changes With Posture
Sponsor: Mayo Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sight Sciences, Inc.Program year202515 payments$11,238openpaymentsdata.cms.gov ↗
- Alcon Vision LLCProgram year202514 payments
- Glaukos CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
84.6%Carbonic Anhydrase Inhibitor23.1%Dorzolamide-Timolol65%Dorzolamide Hcl22%Brinzolamide7%Simbrinza4%Acetazolamide2%Part D≥313 patientsProstaglandin Analog21.4%Latanoprost85%Lumigan7%Travoprost4%Bimatoprost3%Iyuzeh1%Tafluprost1%Part D<11 patients+ 9 more classes in this area
Cardiovascular
8.5%Beta blocker8.5%Timolol Maleate100%Part D≥234 patientsAnti-infectives
2.7%Macrolide1%Erythromycin100%Part D≥44 patientsTetracycline-class Drug0.7%Doxycycline Hyclate100%Part D≥26 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Canaloplasty and trabeculotomy with the OMNI® surgical system in OAG with prior trabecular microbypass stenting
International Ophthalmology
2022 - Canaloplasty and trabeculotomy ab interno with the OMNI system combined with cataract surgery in open-angle glaucoma: 12-month outcomes from the ROMEO study
Journal of Cataract & Refractive Surgery
2020 - Aqueous Humor Outflow Facility by Tonography Does Not Change with Body Position
Investigative Ophthalmology & Visual Science
2010
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”